TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -2 | 1 | -6 | -1 | -30 | -33 | -12 |
| P | %wins | 50 | 100 | 0 | 50 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/3/11 14:17 | 3/1/11 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Lander Russel J | PA | O | VP of Pr | P | 23 | 0.4598 | 0 | 50 | 32 | 208 | D | 15 | -35 | -6 | -4 | -8 | -6 | 0 | 4 | -4 | 2 | -2 | 2 | -30 | -34 |
2/3/11 15:36 | 7/16/10 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Lander Russel J | PA | O | VP of Pr | P.m | 2 | 0.5069 | 0 | 5 | 3 | 158 | D | 28 | -31 | -2 | 0 | 0 | -6 | 0 | 0 | 0 | 0 | -10 | -4 | -30 | -32 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |